Table 1

Summary of studies included in the meta-analysis of diffusion tensor imaging studies of patients with MDD

ControlsPatients
StudyNo. (female)Age, mean (SD) yrNo. (female)Age, mean (SD) yrDiagnosisMedication
Versace et al. (20)24 (15)28 (9)16 (12)33 (10)Recurrent MDDAntidepressants
Blood et al. (25)22 (12)35 (12)22 (12)36 (12)MDDAntidepressants
Liu et al. (26)16 (12)3016 (12)30MDD*Antidepressants
Ma et al. (14)14 (12)27 (7)14 (12)29 (8)First-episode MDDMedication naive
Abe et al. (27)42 (20)48 (13)21 (10)48 (14)MDDNot stated
Steele et al. (28)14 (7)4315 (11)46Recurrent MDDMultiple medications
Wu et al. (29)21 (12)30 (8)23 (13)31 (9)SSDE of MDDMedication-naive
Zou et al. (30)45 (30)31 (10)45 (30)32 (9)Non–late onset MDDAntidepressants
Ouyang et al. (31)18 (9)27.0 (6.8)18 (9)27.4 (6.4)MDDMedication-naive
Zhu et al. (21)25 (14)20.3 (1.7)25 (14)20.6 (1.9)MDD*Medication-naive
Kieseppä et al. (22)20 (10)48.4 (0.3)16 (14)42.0 (11.6)MDDMedication-naive
  • MDD = major depressive disorder; SD = standard devistion; SSDE = single shirt-duration episode.

  • * The sample included only young patients (aged 21 to 35 years) with MDD.

  • 2 patients took antidepressants.

  • Includes anticonvulsant mood stabilizers, antidepressants, antipsychotics, benzodiazepines and lithium treatment.